APA (7th ed.) Citation

MK, J., JA, D. L., DK, M., C, A., JL, E., CL, S., . . . JW, S. (2022). Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial. Frontiers in pharmacology, 13, 1020123. https://doi.org/10.3389/fphar.2022.1020123

Chicago Style (17th ed.) Citation

MK, Jain, et al. "Atovaquone for Treatment of COVID-19: A Prospective Randomized, Double-blind, Placebo-controlled Clinical Trial." Frontiers in Pharmacology 13 (2022): 1020123. https://doi.org/10.3389/fphar.2022.1020123.

MLA (9th ed.) Citation

MK, Jain, et al. "Atovaquone for Treatment of COVID-19: A Prospective Randomized, Double-blind, Placebo-controlled Clinical Trial." Frontiers in Pharmacology, vol. 13, 2022, p. 1020123, https://doi.org/10.3389/fphar.2022.1020123.